With continuous product development and commercialization through molecular diagnosis and genome research, SML Genetree has been recognized in South Korea as an exemplary bio-venture company.
From PCR to NGS, SML Genetree has established a pipeline of excellent products for technologies that are required for molecular diagnosis and genome research.
SML Genetree has gained domestic and global recognition with a series of breakthrough products, including the world’s first HPV NGS diagnostic kit, multiple respiratory syndrome diagnostic kits, HLA NGS kits, STD diagnostic kits, and a Helicobacter pylori drug resistance diagnostic kit. In response to the COVID-19 pandemic, SML Genetree introduced an SARS CoV-2 G kit which obtained MFDS approval (Ministry of Food and Drug Safety of South Korea), Emergency Use Authorization (EUA) by the U.S. FDA, and European integrated use certification (CE IVD).
Real-time polymerase chain reaction (PCR) allows for more precise and rapid identification of infection. PCR products analyze the genes of infectious agents such as viruses and bacteria that cause disease with more accuracy and efficiency for timely detection. In particular, SARS CoV2/RV Fast Kit can provide results for Influenza, RSV, and COVID-19 in less than 1 hour post nucleic acid extraction.
Next Generation Sequencing (NGS) can identify the genotypes and/or mutations of a target by analyzing the genes of a patient or pathogen. This can measure the risk of disease infection, provide an early cancer diagnosis and/or rare disease diagnosis. NGS products include HPV and HLA diagnostic kits and a tuberculosis diagnostic kit currently in development.